[1]
|
Coleman, R.E. (2001) Metastatic Bone Disease: Clinical Features, Pathophysiology and Treatment Strategies. Cancer Treatment Reviews, 27, 165-176. https://doi.org/10.1053/ctrv.2000.0210
|
[2]
|
Selvaggi, G. and Scagliotti, G.V. (2005) Management of Bone Metastases in Cancer: A Review. Critical Reviews in Oncology/Hematology, 56, 365-378. https://doi.org/10.1016/j.critrevonc.2005.03.011
|
[3]
|
Coleman, R.E. (1997) Skeletal Complications of Malignancy. Cancer, 80, 1588-1594.
https://doi.org/10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G
|
[4]
|
李林, 赵祯, 郭兴. 恶性肿瘤骨转移影像学诊断[J]. 中华核医学杂志, 2006, 26(5): 315-318.
|
[5]
|
Fili, S., Karalaki, M. and Schaller, B. (2009) Mechanism of Bone Metastasis: The Role of Osteoprotegerin and of the Host-Tissue Microenvironment-Related Survival Factors. Cancer Letters, 283, 10-19.
https://doi.org/10.1016/j.canlet.2009.01.011
|
[6]
|
Shupp, A.B., Kolb, A.D., Mukhopadhyay, D. and Bussard, K.M. (2018) Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts. Cancers, 10, 182. https://doi.org/10.3390/cancers10060182
|
[7]
|
Macedo, F., Ladeira, K., Pinho, F., Saraiva, N., Bonito, N., Pinto, L. and Goncalves, F. (2017) Bone Metastases: An Overview. Oncology Reviews, 11, 321. https://doi.org/10.4081/oncol.2017.321
|
[8]
|
Robinson, R.G., Preston, D.F., Baxter, K.G., Dusing, R.W. and Spicer, J.A. (1993) Clinical Experience with Strontium-89 in Prostatic and Breast Cancer Patients. Seminars in Oncology, 20, 44-48.
|
[9]
|
Rogers, M.J., Xiong, X., Ji, X., Mönkkönen, J., Russell, R.G., Williamson, M.P., Ebetino, F.H. and Watts, D.J. (1997) Inhibition of Growth of Dictyostelium discoideum Amoebae by Bisphosphonate Drugs Is Dependent on Cellular Uptake. Pharmaceutical Research, 14, 625-630. https://doi.org/10.1023/A:1012157212793
|
[10]
|
郝平. 骨转移性肿瘤的非外科治疗选择[J]. 实用肿瘤杂志, 2008, 23(4): 301-303.
|
[11]
|
Green, J.R. and Rogers, M.J. (2002) Pharmacologic Profile of Zoledronic Acid: A Highly Potent Inhibitor of Bone Resorption. Drug Development Research, 55, 210-224. https://doi.org/10.1002/ddr.10071
|
[12]
|
Mhaskar, R., Redzepovic, J., Wheatley, K., Clark, O.A., Miladinovic, B., Glasmacher, A., Kumar, A. and Djulbegovic, B. (2010) Bisphosphonates in Multiple Myeloma. The Cochrane Database of Systematic Reviews, 3, CD003188.
https://doi.org/10.1002/14651858.CD003188.pub2
|
[13]
|
Huang, W.W., Huang, C., Liu, J., Zheng, H.Y. and Lin, L. (2012) Zoledronic Acid as an Adjuvant Therapy in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. PLoS ONE, 7, e40783.
https://doi.org/10.1371/journal.pone.0040783
|
[14]
|
Steger, G.G. and Bartsch, R. (2011) Denosumab for the Treatment of Bone Metastases in Breast Cancer: Evidence and Opinion. Therapeutic Advances in Medical Oncology, 3, 233-243. https://doi.org/10.1177/1758834011412656
|